BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26114880)

  • 1. Development of nanotoxicology: implications for drug delivery and medical devices.
    Bhattacharjee S; Brayden DJ
    Nanomedicine (Lond); 2015 Jul; 10(14):2289-305. PubMed ID: 26114880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotoxicology and nanomedicine: making hard decisions.
    Linkov I; Satterstrom FK; Corey LM
    Nanomedicine; 2008 Jun; 4(2):167-71. PubMed ID: 18329962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotoxicology: signs of stress.
    Stone V; Donaldson K
    Nat Nanotechnol; 2006 Oct; 1(1):23-4. PubMed ID: 18654137
    [No Abstract]   [Full Text] [Related]  

  • 5. Advanced nuclear analytical and related techniques for the growing challenges in nanotoxicology.
    Chen C; Li YF; Qu Y; Chai Z; Zhao Y
    Chem Soc Rev; 2013 Nov; 42(21):8266-303. PubMed ID: 23868609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CompNanoTox2015: novel perspectives from a European conference on computational nanotoxicology on predictive nanotoxicology.
    Bañares MA; Haase A; Tran L; Lobaskin V; Oberdörster G; Rallo R; Leszczynski J; Hoet P; Korenstein R; Hardy B; Puzyn T
    Nanotoxicology; 2017 Sep; 11(7):839-845. PubMed ID: 28885075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. At the Crossroads of Nanotoxicology in vitro: Past Achievements and Current Challenges.
    Hussain SM; Warheit DB; Ng SP; Comfort KK; Grabinski CM; Braydich-Stolle LK
    Toxicol Sci; 2015 Sep; 147(1):5-16. PubMed ID: 26310852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multilaboratory Toxicological Assessment of a Panel of 10 Engineered Nanomaterials to Human Health--ENPRA Project--The Highlights, Limitations, and Current and Future Challenges.
    Kermanizadeh A; Gosens I; MacCalman L; Johnston H; Danielsen PH; Jacobsen NR; Lenz AG; Fernandes T; Schins RP; Cassee FR; Wallin H; Kreyling W; Stoeger T; Loft S; Møller P; Tran L; Stone V
    J Toxicol Environ Health B Crit Rev; 2016; 19(1):1-28. PubMed ID: 27030582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology, nanotoxicology, and neuroscience.
    Suh WH; Suslick KS; Stucky GD; Suh YH
    Prog Neurobiol; 2009 Feb; 87(3):133-70. PubMed ID: 18926873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterials.
    Pal AK; Bello D; Cohen J; Demokritou P
    Nanotoxicology; 2015; 9(7):871-85. PubMed ID: 25672815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historical overview of nanotechnology and nanotoxicology.
    Santamaria A
    Methods Mol Biol; 2012; 926():1-12. PubMed ID: 22975953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in nanotoxicology.
    Bolt HM; Marchan R; Hengstler JG
    Arch Toxicol; 2013 Jun; 87(6):927-8. PubMed ID: 22526375
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies].
    Hirose A; Nishimura T; Kanno J
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):15-25. PubMed ID: 20306702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges.
    Johnston H; Pojana G; Zuin S; Jacobsen NR; Møller P; Loft S; Semmler-Behnke M; McGuiness C; Balharry D; Marcomini A; Wallin H; Kreyling W; Donaldson K; Tran L; Stone V
    Crit Rev Toxicol; 2013 Jan; 43(1):1-20. PubMed ID: 23126553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential pitfalls of nanotechnology in its applications to medicine: immune incompatibility of nanodevices.
    Shetty RC
    Med Hypotheses; 2005; 65(5):998-9. PubMed ID: 16023299
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanomaterials and lab-on-a-chip technologies.
    Medina-Sánchez M; Miserere S; Merkoçi A
    Lab Chip; 2012 May; 12(11):1932-43. PubMed ID: 22517169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A knowledge-based search engine to navigate the information thicket of nanotoxicology.
    Sauer UG; Kneuer C; Tentschert J; Wächter T; Schroeder M; Butzke D; Luch A; Liebsch M; Grune B; Götz ME
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):47-52. PubMed ID: 20850491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The primacy of physicochemical characterization of nanomaterials for reliable toxicity assessment: a review of the zebrafish nanotoxicology model.
    Bohnsack JP; Assemi S; Miller JD; Furgeson DY
    Methods Mol Biol; 2012; 926():261-316. PubMed ID: 22975971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics.
    Piperigkou Z; Karamanou K; Engin AB; Gialeli C; Docea AO; Vynios DH; Pavão MS; Golokhvast KS; Shtilman MI; Argiris A; Shishatskaya E; Tsatsakis AM
    Food Chem Toxicol; 2016 May; 91():42-57. PubMed ID: 26969113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.